Skip to content
OpenCapital
Get started

DFDV DFDV Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$2.7M+828%
Gross profit$2.6M+814%
Operating income-$55.2M-6,154%
Net income-$83.4M-10,619%
EPS (diluted)-$3.18-3,875%

Balance sheet

See full
Cash & equivalents$3.7M+104%
Total debt$127.8M+226,535%
Total equity$10.2M+258%
Total assets$229.7M+5,425%

Cash flow

See full
Operating cash flow-$9.8M-1,151%
CapEx$500.0-95.0%
Free cash flow-$10.9M-5,681%

Valuation

See full
Market cap$88.55M-62.4%
Enterprise value$212.64M-21.3%
P/S6.4×-60.4×

Profitability

See full
Gross margin97.5%-0.9pp
Operating margin-659.3%-919pp
Net margin-1,136.4%-1,303pp
FCF margin-116.2%+98.4pp

Returns & leverage

See full
Return on equity-2,398.4%-2,467pp
Debt / equity12.5×+12.5×
Current ratio1.4×-1.5×